Gestational Diabetes Clinical Trials

Find Gestational Diabetes Clinical Trials Near You

Islet Function in Gestational Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: f
View:

• Pregnant individuals with a viable singleton pregnancy who have completed second trimester gestational diabetes screening and are eligible for classification as either gestational diabetes mellitus or no gestational diabetes mellitus.

• Participants must be willing and able to provide informed consent and complete planned pregnancy and postpartum study visits.

Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
Contact Information
Primary
Jeanette Laugen
laugen.jeanette@mayo.edu
507-255-8110
Backup
Amy Zipse
zipse.amy@mayo.edu
507-255-9278
Time Frame
Start Date: 2026-09
Estimated Completion Date: 2030-12
Participants
Target number of participants: 90
Treatments
Experimental: Women With Gestational Diabetes Mellitus
Pregnant participants diagnosed with gestational diabetes mellitus who complete pregnancy and postpartum metabolic study visits.
Experimental: Women Without Gestational Diabetes Mellitus
Pregnant participants without gestational diabetes mellitus, matched to the gestational diabetes group by parity, age, ethnicity, gestational week at diagnosis comparator timepoint, and first trimester body mass index.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov